
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 69
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT06233292 | A Study of ZG005 in Patients With Advanced Solid Tumors | ||
NCT04435392 | Jaktinib Hydrochloride Cream For Atopic Dermatitis | ||
NCT04971473 | Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal | ||
NCT02870582 | Donafenib for Previously Treated Metastatic Colorectal Cancer | ||
NCT06558227 | Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma | ||
NCT05864573 | Study of ZGGS15 in Patients With Advanced Solid Tumors | ||
NCT04312594 | Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary Fibrosis | ||
NCT05686629 | An Efficacy and Safety Study of Jaktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus Pneumonia | ||
NCT04612712 | A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal Tumors | ||
NCT03611426 | Topical rhThrombin as an Adjunct to Hemostasis During Segmental Hepatectomy | ||
NCT06440057 | Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma. | ||
NCT06372626 | Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma. | ||
NCT04816123 | The Mass Balance and Biotransformation of [14C]Donafenib in Healthy Adult Man | ||
NCT02489201 | A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer | ||
NCT05279001 | A Safety and Tolerability Study of Jaktinib | ||
NCT04993404 | Pharmacokinetics Of Jaktinib In Subjects With Hepatic Impairment And Normal Hepatic Function | ||
NCT06193148 | A Study to Evaluate the Effect of Jaktinib on QT/QTc Interval in Healthy Participants | ||
NCT06241235 | Study of ZG005 in Combination With Paclitaxel+Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma | ||
NCT04851535 | Study of Jaktinib In Patients With Myelofibrosis Who Were Relapsed or Refractory of Ruxolitinib Treatment. | ||
NCT05526222 | A Phase III Study of Jaktinib in Adults With Moderate and Severe Atopic Dermatitis | ||
NCT04539639 | Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis | ||
NCT05688839 | A Study of Jaktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus Pneumonia | ||
NCT04445363 | A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata | ||
NCT04472858 | A Study of CS1001 in Combination With Donafenib in Subjects With Advanced Solid Tumors | ||
NCT02489916 | Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer | ||
NCT02870569 | Phase 2 Trial of Donafenib in 131I-Refractory Differentiated Thyroid Cancer | ||
NCT02645981 | Efficacy and Safety of Donafenib in Patients With Advanced Hepatocellular Carcinoma | ||
NCT06592638 | A Phase 1 Dose Escalation Study of ZG006 in Patients with Small Cell Lung Cancer | ||
NCT04402723 | Combination of Donafenib and Cytarabine/Daunorubicin in Relapsed AML | ||
NCT06132243 | Comparative Study on Pharmacokinetics of Two Formulations of Jaktinib in Healthy Adults Under Fasting Conditions | ||
NCT05150717 | ADME Study of [14C]-Jaktinib in Healthy Male Subjects | ||
NCT06237413 | A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid Tumours | ||
NCT04034134 | Study to Evaluate the Safety and Efficacy ofJaktinib Hydrochloride Tablets in Severe Alopecia Areata | ||
NCT04211922 | Alkotinib Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib | ||
NCT06283719 | Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer | ||
NCT05978284 | Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma | ||
NCT05861102 | Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS) | ||
NCT02489214 | Donafenib Monotherapy for Previously Treated Metastatic Gastric Cancer | ||
NCT06246695 | A Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of Jaktinib in Healthy Volunteers | ||
NCT03602495 | A Phase 3 Study of Donafenib in Patients With Radioiodine-refractory Differentiated Thyroid Cancer | ||
NCT05584800 | Study of ZGGS18 in Patients With Advanced Solid Tumors | ||
NCT04507659 | Jaktinib Hydrochloride Tablets In The Treatment of Active Ankylosing Spondylitis | ||
NCT05676242 | A Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic Dermatitis | ||
NCT06237400 | A Study of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors. | ||
NCT04503902 | Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular Carcinoma | ||
NCT05161143 | Donafenib Combined With TACE as Adjuvant Therapy of Patients With Hepatocellular Carcinoma | ||
NCT03314402 | The Tolerance, Pharmacokinetics of Jaktinib in Healthy Volunteers | ||
NCT04032821 | To Evaluate the Effect of Food on the Pharmacokinetic Characteristics of Alkotinib Capsules in Healthy Subjects | ||
NCT04964284 | Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer | ||
NCT05877664 | Study of ZG0895.HCl in Patients With Advanced Solid Tumors |